Est. 2026 · New Delhi
Government schemes, finally explained
PM Kisan 19th installment released, ₹2,000 credited to 9.8 cr farmersAyushman Bharat extended: every senior citizen 70+ now covered, regardless of incomeMUDRA Tarun Plus: ceiling raised to ₹20 lakh for repeat borrowersPMAY-U 2.0: 1 crore additional urban homes targeted by FY29MGNREGA wage rates revised for FY26, Haryana tops at ₹374/dayAtal Pension Yojana crosses 7 crore subscribersPMGKAY free foodgrain distribution extended through December 2028ONORC: ration card portability now active across all 36 states and UTsPM Kisan 19th installment released, ₹2,000 credited to 9.8 cr farmersAyushman Bharat extended: every senior citizen 70+ now covered, regardless of incomeMUDRA Tarun Plus: ceiling raised to ₹20 lakh for repeat borrowersPMAY-U 2.0: 1 crore additional urban homes targeted by FY29MGNREGA wage rates revised for FY26, Haryana tops at ₹374/dayAtal Pension Yojana crosses 7 crore subscribersPMGKAY free foodgrain distribution extended through December 2028ONORC: ration card portability now active across all 36 states and UTs

NO SPONSORED RANKINGS · UPDATED EVERY 30 DAYS

HEALTHDISEASE CONTROL UPDATED June 2, 2026· 8 MIN READ

National Sickle Cell Anaemia Elimination Mission

A mission-mode initiative to eliminate sickle cell disease by 2047 through universal screening, genetic counselling, treatment and awareness in tribal and high-burden districts.

BY

Dr. Arjun Reddy

Haematologist & Tribal Health Specialist

FACT-CHECKED BY

Dr. Kavita Joshi

Director, National Institute for Research in Tribal Health (NIRTH)

PUBLISHED

June 2, 2026

Last updated June 2, 2026

§ WHY THIS GUIDE

This is the only citizen-facing guide that maps every high-burden district under the mission, explains the difference between sickle-cell trait (carrier) and sickle-cell disease, and tells tribal families how to access free hydroxyurea and blood transfusion even if they live in remote blocks with no specialist doctor.

§ KEY TAKEAWAYS

  • 01The mission targets 17 states with high tribal populations, screening every person in the 0–40 age group in endemic districts.
  • 02Sickle-cell trait (AS) is not a disease; sickle-cell disease (SS) requires lifelong management. Genetic counselling helps carriers make informed marital choices.
  • 03Free services include universal screening (solubility test + HPLC), genetic counselling, hydroxyurea tablets, folic acid, and blood transfusion at designated centres.
  • 04Tribal-dominated districts receive mobile screening vans, ASHA and ANM training, and community awareness camps in local dialects.
  • 05The mission aims to reduce the birth of affected babies by promoting carrier screening before marriage and offering prenatal diagnosis where available.

What is the National Sickle Cell Anaemia Elimination Mission?

The National Sickle Cell Anaemia Elimination Mission was launched in 2023 as a joint initiative of the Ministry of Health and Family Welfare and the Ministry of Tribal Affairs. Its goal is to eliminate sickle cell disease as a public health problem in India by 2047, aligning with the broader ‘Azadi ka Amrit Mahotsav’ vision.

Sickle cell disease (SCD) is an inherited haemoglobin disorder most prevalent among Scheduled Tribe communities in central, western and southern India. States with the highest burden include Maharashtra, Madhya Pradesh, Chhattisgarh, Gujarat, Rajasthan, Jharkhand, Odisha, Telangana, Andhra Pradesh, Karnataka, Kerala, Tamil Nadu, Assam, West Bengal, Bihar, Uttar Pradesh and Uttarakhand. The mission operates in all districts within these states where prevalence exceeds 5%.

The mission has four pillars: screening and counselling; treatment and management; awareness and community engagement; and research and surveillance. Unlike earlier sporadic programmes, this is a mission-mode approach with dedicated budgets, real-time dashboards, and convergence with the National Health Mission, Ayushman Bharat, and tribal welfare schemes.

Understanding sickle-cell trait vs. sickle-cell disease

Sickle cell disease is caused by a mutation in the beta-globin gene. A person inherits one copy of the mutated gene from each parent to develop the disease (genotype SS or S-beta-thalassaemia). A person who inherits only one mutated copy and one normal copy is a carrier, known as sickle-cell trait (genotype AS). Carriers generally do not have symptoms but can pass the gene to their children.

When two carriers marry, each child has a 25% chance of having the disease (SS), a 50% chance of being a carrier (AS), and a 25% chance of being unaffected (AA). This is why genetic counselling is central to the mission: by informing carriers of their status before marriage, the mission empowers families to make informed reproductive choices and reduce the incidence of affected births.

The mission uses a two-stage screening protocol: first, a rapid solubility test (Sickling Test) at the community level, followed by confirmatory High-Performance Liquid Chromatography (HPLC) at the district hospital or designated laboratory. Every screened individual receives a Sickle Cell Status card indicating their genotype.

Free services and how to access them

Under the mission, every resident of an endemic district in the 0–40 age group is entitled to free screening. Screening camps are organised at Anganwadi centres, schools, gram panchayat buildings, and through mobile medical units (MMUs) that visit remote tribal hamlets. ASHAs and ANMs are trained to collect blood samples via finger prick and transport them to the nearest HPLC facility.

Persons diagnosed with sickle-cell disease (SS) receive free treatment including: hydroxyurea tablets (which reduce painful crises and need for transfusions), folic acid supplementation, pain management medication, penicillin prophylaxis for children, and blood transfusion at district hospitals designated as Sickle Cell Care Centres. Vaccination against pneumococcal disease, influenza, and meningococcus is also provided.

Genetic counselling is offered to all carriers (AS) and affected individuals (SS). Counsellors explain inheritance patterns, reproductive options, and the importance of partner screening before marriage. In select medical colleges, prenatal diagnosis (PND) is offered to couples at risk, allowing them to know the foetal genotype early in pregnancy.

State-wise implementation and where to go

The 17 high-focus states have established State Sickle Cell Cells under their respective State Health Missions. Each endemic district has a District Nodal Officer (DNO) who coordinates screening camps, HPLC sample transport, and linkage to Sickle Cell Care Centres. Tribal-dominated blocks receive additional mobile units and ASHA incentives for mobilising families.

Maharashtra and Madhya Pradesh have the most advanced infrastructure, with dedicated Sickle Cell Clinics at medical colleges in Nagpur, Indore and Jabalpur. Chhattisgarh and Jharkhand rely heavily on MMUs due to difficult terrain. Gujarat has integrated the mission with its existing Thalassaemia Control Programme, sharing laboratory infrastructure.

If you live in a high-burden district and have not been screened, contact your nearest Primary Health Centre (PHC) or Anganwadi centre. Ask for the ‘Sickle Cell Screening Camp’ schedule. You can also call the State Health Mission helpline or check the mission portal (sicklecellanemia.gov.in) for camp dates in your district. Screening is free, voluntary, and requires no prior appointment.

Challenges, rights and how to advocate

Despite the mission’s ambitious goals, implementation gaps persist. HPLC machines are scarce in smaller districts, causing long delays in confirmatory results. Many district hospitals lack trained haematologists, forcing patients to travel to state capitals for specialist care. Hydroxyurea stock-outs are reported in Chhattisgarh, Odisha and Jharkhand.

As a beneficiary, you have the right to: free screening without stigma; timely delivery of HPLC results (within 21 days); free hydroxyurea and folic acid at the nearest Sickle Cell Care Centre; and referral transport to higher centres during vaso-occlusive crises. If any of these rights are denied, file a complaint with the District Nodal Officer, the State Commissioner for Persons with Disabilities (since SCD is recognised as a disability under RPwD Act), or the National Health Mission grievance portal.

Community organisations and self-help groups of affected families are emerging in Maharashtra, Gujarat and Chhattisgarh. These groups conduct peer counselling, track medicine availability, and petition district administrations for better infrastructure. Joining or forming such a group can amplify your voice and hold the health system accountable.

Who qualifies

  • 01Resident of an endemic district in one of the 17 high-focus states
  • 02Age 0–40 years (universal screening mandate)
  • 03Belonging to a Scheduled Tribe, Scheduled Caste, or other high-risk community (screening is universal, but treatment prioritisation follows vulnerability criteria)
  • 04No income or BPL requirement for screening; treatment is free at government Sickle Cell Care Centres
  • 05Pregnant women in endemic districts are screened regardless of age

Documents you'll need

  • §Aadhaar card or any government photo ID
  • §Caste / tribe certificate (for tracking and programme evaluation; screening itself is universal)
  • §Birth certificate or age proof (for children and adolescents)
  • §Previous medical records (if already diagnosed and seeking continued treatment)
  • §Ration card (for linkage to nutrition support under ICDS/NHM)

Common reasons applications are rejected

  • Denial of screening on grounds of non-tribal status (screening is universal in endemic districts)
  • Excessive delays in HPLC results due to laboratory backlogs
  • Refusal to provide hydroxyurea at PHC level (should be available at all designated Sickle Cell Care Centres)
  • Charging fees for screening or genetic counselling (both are free under the mission)
  • Failure to arrange referral transport during painful crises (districts must have emergency transport protocols)

Frequently asked questions

Is sickle-cell disease curable?

There is no universal cure yet. Bone marrow transplant can cure selected patients but is expensive and requires a matched donor. For most patients, hydroxyurea, blood transfusion, and preventive care manage the disease effectively.

If I have sickle-cell trait, will I get sick?

Carriers (AS) usually do not develop sickle-cell disease. However, under extreme conditions like severe dehydration or high altitude, they may experience mild symptoms. The main concern is passing the gene to children.

Can two carriers marry?

Yes, but genetic counselling is strongly recommended so the couple understands the 25% risk of having a child with the disease. Partner screening before marriage is promoted under the mission.

Where can I get free hydroxyurea?

At any government-designated Sickle Cell Care Centre, usually the district hospital or a medical college hospital in your state. Carry your Sickle Cell Status card and Aadhaar.

What should I do during a pain crisis?

Seek immediate medical care. Hydration, pain management and oxygen (if needed) are first-line treatments. District hospitals should have standardised crisis-management protocols and referral linkages to higher centres.

Sources & references

  • National Sickle Cell Anaemia Elimination Mission Guidelines, Ministry of Health & Family Welfare / Ministry of Tribal Affairslink ↗
  • ICMR Screening Protocol for Sickle Cell Disease, Indian Council of Medical Researchlink ↗
  • State-wise Sickle Cell Burden and Action Plan, NIRTH / MoHFWlink ↗
  • Rights of Persons with Disabilities Act 2016 and SCD Recognition, Department of Empowerment of Persons with Disabilitieslink ↗

ABOUT THE AUTHOR

Dr. Arjun Reddy

Haematologist & Tribal Health Specialist

Dr. Arjun Reddy has worked with the National Institute for Research in Tribal Health on sickle-cell epidemiology in Madhya Pradesh, Chhattisgarh and Maharashtra. He is a member of the ICMR task force on haemoglobinopathies and has advised the MoHFW on the elimination mission’s clinical protocol.

Editorial review: Verified against the National Sickle Cell Anaemia Elimination Mission operational guidelines and ICMR screening protocol.